NOW / 0–18 months
Bound the material
A sealed nonclinical module: one payload class, characterized command-to-release behavior, passive-leak measurement, service concept, and explicit failure modes.
Menu
PORT-COUPLED MATERIAL INTERFACE
Programmable
hydrogel for
heightened
sensory states.
A port-coupled material interface designed to translate governed electrochemical inputs into precisely shaped patterns of sensation.
A compact crown port divides into a primary cranio-cervical tract and a finer conceptual branch curving toward the anterior brain. Both routes remain sealed.
THE INVERSION
An inner source becomes a serviceable interface.
Amṛta supplies an image of source, flow, and preservation. It shapes the question, not the mechanism.
Ambrosine translates that image into a port, confined hydrogel, bounded trigger, and chosen dock. Experiments decide the answer.
Simulation THEORETICAL MATERIAL-TO-STATE LOOP
Program the matter.
Bound the output.
Study the state.
A service port would maintain the confined gel. An authorized signal would change release behavior. A chosen dock would make the local output measurable.
MAINTENANCE PATH
Refill one contained reservoir.
A clinician would use the implanted port to refill a defined payload reservoir coupled to the hydrogel chamber. The responsive gel would remain confined inside the assembly.
- Input
- Sterile payload cartridge
- Material change
- Known reservoir condition restored
- Measured output
- Documented starting state
ENGINEERING REQUIREMENT
LONG-RANGE QUESTION
Could precisely timed local delivery make reported qualities such as cooling, sweetness, luminosity, stillness, and continuity measurable?
Five-year hypothesis DEVELOPMENT PATH
From bench proof
to clinical feasibility.
Each stage produces a concrete partner decision: proceed, redesign, or stop.
NEXT / 18–36 months
Integrate one program
A disease-specific prototype, manufacturing-representative lots, relevant-animal evidence, retrieval data, and formal regulatory feedback—only if prior gates pass.
FIVE-YEAR UPSIDE / 36–60 months
Reach feasibility
An IDE-enabling package or limited early-feasibility work in patients whose disease already justifies an implant. Approval is not promised.
THE PARTNER PROGRAM
Build the interface
between material
and inner state.
Ambrosine brings hydrogel, implant, clinical, and contemplative expertise around one measurable interface.